CCCC's logo.
Ticker Symbol: CCCC

C4 Therapeutics Inc

$41.10 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001662579

Company Profile

C4 Therapeutics is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer and other diseases. This targeted protein degradation approach offers advantages over traditional therapies, including the potential to treat a wider range of diseases, reduce drug resistance, achieve higher potency, and decrease side effects through greater selectivity.

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: N/A
CEO: N/A
Tags:
  • Health Technology
  • Biotechnology

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $1.87
Change: $0.02 ( 1.08%)
Days Range: $1.77 - $1.95
Beta: 1.56
52wk. High: $10.42
52wk. Low: $1.51
Ytd. Change -67.56%
50 Day Moving Average: $2.00
200 Day Moving Average: $2.99
Shares Outstanding: 49190855

Valuation

Market Cap: 9.2B
PE Ratio: -0.66
EPS (TTM): -2.85

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A